Moving Toward Precision Medicine in Adult Acute Myeloid Leukemia

home / peer-exchange / aml-precision-medicine
Risk-directed Approaches to AML Therapy

EP. 1: Risk-directed Approaches to AML Therapy

January 11th 2017
CPX-351 for Older Patients with AML

EP. 2: CPX-351 for Older Patients with AML

January 11th 2017
MRD Assessment and Consolidation in AML

EP. 3: MRD Assessment and Consolidation in AML

January 11th 2017
Maintenance Therapy for AML

EP. 4: Maintenance Therapy for AML

January 11th 2017
Emerging Role of FLT3 Inhibitors in AML: Midostaurin

EP. 5: Emerging Role of FLT3 Inhibitors in AML: Midostaurin

January 11th 2017
Quizartinib in AML

EP. 6: Quizartinib in AML

January 11th 2017
IDH1/2 inhibitors for AML

EP. 7: IDH1/2 inhibitors for AML

January 11th 2017
Vosaroxin/Cytarabine in AML

EP. 8: Vosaroxin/Cytarabine in AML

January 11th 2017
Venetoclax in AML

EP. 9: Venetoclax in AML

January 11th 2017
Emerging Therapies for Acute Myeloid Leukemia

EP. 10: Emerging Therapies for Acute Myeloid Leukemia

January 11th 2017